At SSS, our team of experts work proudly alongside our clients to enable answers to life-threatening diseases through research, trials, and analytic assessments. We internalize our mission of improving public health worldwide by partnering with clients and organizations around the world to improve patient outcomes. Learn more: https://lnkd.in/etRjyjy
SSS Research Update: Medications associated with antinuclear antibodies in individuals not risk factors in general population. Read the article from SSS senior statistician Gregg Dinse (first author) and researcher Caroll Co: https://lnkd.in/g3gEF77
This week, SSS staff gathered to celebrate Gale Maynard’s 35 years of dedication to SSS. Gale has played an influential role in our mission to improve public health worldwide. Thank you Gale and congrats on your retirement!
At SSS, we are passionate about clinical and biomedical research, epidemiology and public health research, health policy, and program evaluation. Learn more about the passion that drives our mission: https://lnkd.in/eEywwBt